WallStreetZenWallStreetZen

NYSE: BSX
Boston Scientific Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Boston Scientific revenue was $16.75B for the trailing 12 months ending Dec 31, 2024, with 16.7% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $4.6B, up 8.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BSX annual revenue was $16.7B, with 17.6% growth year-over-year.

BSX past revenue growth

How has BSX's revenue growth performed historically?

Company
17.61%
Industry
10.59%
Market
20.87%
BSX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BSX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BSX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BSX revenue history

Current Revenue
$16.7B
Current Earnings
$1.9B
Current Profit Margin
11.1%

Be the first to know when BSX announces revenue.

BSX Revenue History By Year

BSX Yearly RevenueBSX RevenueBSX ChangeBSX Revenue Growth
2024-12-31$16.75B$2.51B+17.61%
2023-12-31$14.24B$1.56B+12.29%
2022-12-31$12.68B$794.00M+6.68%
2021-12-31$11.89B$1.98B+19.92%
2020-12-31$9.91B-$822.00M-7.66%
2019-12-31$10.74B$912.00M+9.28%
2018-12-31$9.82B$775.00M+8.57%
2017-12-31$9.05B$662.00M+7.89%
2016-12-31$8.39B$909.00M+12.16%
2015-12-31$7.48B$97.00M+1.31%
2014-12-31$7.38B$237.00M+3.32%
2013-12-31$7.14B-$106.00M-1.46%
2012-12-31$7.25B-$373.00M-4.89%
2011-12-31$7.62B-$184.00M-2.36%
2010-12-31$7.81B-$382.00M-4.67%
2009-12-31$8.19B$138.00M+1.71%
2008-12-31$8.05B-$307.00M-3.67%
2007-12-31$8.36B$536.00M+6.85%
2006-12-31$7.82B$1.54B+24.48%
2005-12-31$6.28B$659.00M+11.72%
2004-12-31$5.62B$2.15B+61.80%
2003-12-31$3.48B$557.00M+19.08%
2002-12-31$2.92B$246.00M+9.20%
2001-12-31$2.67B$9.00M+0.34%
2000-12-31$2.66B-$178.00M-6.26%
1999-12-31$2.84B$608.00M+27.22%
1998-12-31$2.23B$403.00M+22.01%
1997-12-31$1.83B$279.76M+18.03%
1996-12-31$1.55B$360.42M+30.27%
1995-12-31$1.19B$302.25M+34.02%
1994-12-31$888.57MN/AN/A

1 of 3

Boston Scientific Revenue FAQ

What was BSX's revenue last quarter?

On Invalid Date, Boston Scientific (NYSE: BSX) reported Q4 2024 revenue of $4.56 billion up 22.44% year over year. In the same quarter last year, Boston Scientific's revenue was $3.73 billion.

What was Boston Scientific's revenue in 2024?

Boston Scientific's annual revenue for the twelve months ending Dec 31, 2024 was $16.75 billion, a 17.61% increase year over year.

How much does Boston Scientific make in a day?

Based on Boston Scientific annual revenue for the past five years, BSX makes an average of $35,873,972.60 per day.

What was Boston Scientific's annual revenue growth in the past year?

As of Q2 2025, Boston Scientific's revenue has grown 17.61% year over year. This is 7.02 percentage points higher than the US Medical Devices industry revenue growth rate of 10.59%. Boston Scientific's revenue in the past year totaled $16.75 billion.

How much does Boston Scientific make in a year?

Boston Scientific's revenue by year for the past five years is:
  • Boston Scientific's revenue for the twelve months ending Dec 31, 2024 was $16.75 billion, a 17.61% increase year over year.
  • Boston Scientific's annual revenue for Dec 31, 2023 was $14.24 billion, a 12.29% increase from 2022.
  • Boston Scientific's annual revenue for 2022 was $12.68 billion, a 6.68% increase from 2021.
  • Boston Scientific's annual revenue for 2021 was $11.89 billion, a 19.92% increase from 2020.
  • Boston Scientific's annual revenue for 2020 was $9.91 billion, a 7.66% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.